Colgate-Palmolive (NYSE:CL) Receives $102.06 Average PT from Analysts

Colgate-Palmolive (NYSE:CL) has been given a consensus rating of “Hold” by the twenty-one analysts that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $102.06.

Several equities research analysts have recently weighed in on CL shares. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. TD Cowen cut their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. UBS Group decreased their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. Stifel Nicolaus dropped their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Finally, StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, March 25th.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $92.73 on Friday. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The company has a market cap of $75.25 billion, a price-to-earnings ratio of 26.34, a PEG ratio of 4.20 and a beta of 0.40. The firm’s 50-day moving average is $89.69 and its 200-day moving average is $93.52. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the company earned $0.87 earnings per share. Equities research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive announced that its Board of Directors has approved a stock repurchase program on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to repurchase up to 6.8% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be given a $0.52 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.24%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.50. Colgate-Palmolive’s dividend payout ratio (DPR) is 59.09%.

Hedge Funds Weigh In On Colgate-Palmolive

Several hedge funds have recently modified their holdings of CL. Kohmann Bosshard Financial Services LLC acquired a new position in Colgate-Palmolive during the fourth quarter valued at approximately $26,000. Centricity Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $27,000. Vermillion Wealth Management Inc. bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $31,000. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive during the fourth quarter worth $32,000. Finally, Briaud Financial Planning Inc bought a new stake in Colgate-Palmolive during the fourth quarter worth $32,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.